BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31165554)

  • 21. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
    Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
    PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
    Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration.
    Ozturk K; Nascene D
    J Neuroimaging; 2021 May; 31(3):602-608. PubMed ID: 33783925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
    Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
    Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
    Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
    Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
    Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
    Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
    Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
    Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
    Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
    Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study.
    Choi Y; Jang J; Kim J; Nam Y; Shin NY; Ahn KJ; Jeon SS; Kim BS
    Radiology; 2020 Oct; 297(1):143-150. PubMed ID: 32692298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
    Hu HH; Pokorney A; Towbin RB; Miller JH
    Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
    Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
    Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
    Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
    AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging.
    Cao Y; Zhang Y; Shih G; Zhang Y; Bohmart A; Hecht EM; Prince MR
    Invest Radiol; 2016 Nov; 51(11):677-682. PubMed ID: 27272543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.